Proteomic mapping of Drosophila transgenic elav.L-GAL4/+ brain as a tool to illuminate neuropathology mechanisms.
Athanassios D VelentzasStamatia A KatarachiaNiki E SagioglouMaria M TsiokaAthanasios K AnagnostopoulosVassiliki E MpakouEleni I TheotokiAikaterini F GiannopoulouKonstantinos E KeramarisIssidora S PapassideriGeorge Th TsangarisDimitrios J StravopodisPublished in: Scientific reports (2020)
Drosophila brain has emerged as a powerful model system for the investigation of genes being related to neurological pathologies. To map the proteomic landscape of fly brain, in a high-resolution scale, we herein employed a nano liquid chromatography-tandem mass spectrometry technology, and high-content catalogues of 7,663 unique peptides and 2,335 single proteins were generated. Protein-data processing, through UniProt, DAVID, KEGG and PANTHER bioinformatics subroutines, led to fly brain-protein classification, according to sub-cellular topology, molecular function, implication in signaling and contribution to neuronal diseases. Given the importance of Ubiquitin Proteasome System (UPS) in neuropathologies and by using the almost completely reassembled UPS, we genetically targeted genes encoding components of the ubiquitination-dependent protein-degradation machinery. This analysis showed that driving RNAi toward proteasome components and regulators, using the GAL4-elav.L driver, resulted in changes to longevity and climbing-activity patterns during aging. Our proteomic map is expected to advance the existing knowledge regarding brain biology in animal species of major translational-research value and economical interest.
Keyphrases
- resting state
- white matter
- high resolution
- cerebral ischemia
- liquid chromatography tandem mass spectrometry
- functional connectivity
- healthcare
- protein protein
- amino acid
- small molecule
- genome wide
- dna methylation
- mass spectrometry
- binding protein
- gene expression
- electronic health record
- simultaneous determination
- artificial intelligence
- high density
- cancer therapy
- drug delivery
- brain injury
- tandem mass spectrometry
- genome wide identification
- genome wide analysis